Proceedings: The effect of various putative neurotransmitters on the release of CRH from the hypophysiotrophic hypothalamus in vitro.
D000109:Acetylcholine / Q000037:antagonists & inhibitors / Q000494:pharmacology; D000305:Adrenal Cortex Hormones / Q000096:biosynthesis; D000311:Adrenal Glands / Q000378:metabolism; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001681:Biological Assay; D003346:Corticotropin-Releasing Hormone / Q000378:metabolism*; D006584:Hexamethonium Compounds / Q000494:pharmacology; D007031:Hypothalamus / Q000187:drug effects / Q000378:metabolism*; D066298:In Vitro Techniques; D008784:Methysergide / Q000494:pharmacology; D009433:Neural Inhibition; D018377:Neurotransmitter Agents / Q000494:pharmacology*; D009638:Norepinephrine / Q000037:antagonists & inhibitors; D010646:Phentolamine / Q000494:pharmacology; D051381:Rats; D012701:Serotonin / Q000494:pharmacology; D012702:Serotonin Antagonists
D000305:Adrenal Cortex Hormones; D006584:Hexamethonium Compounds; D018377:Neurotransmitter Agents; D012702:Serotonin Antagonists; D012701:Serotonin; D001285:Atropine; D003346:Corticotropin-Releasing Hormone; D000109:Acetylcholine; D009638:Norepinephrine; D008784:Methysergide; D010646:Phentolamine